Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Hepatology Communications|November 2, 2023
Cognitive function, self-management, and outcomes among liver transplant recipients: LivCog, a multicenter, prospective studyMarina Serper, Adwait Chafale, Alex Burdzy, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2026
Temporal Association Between COVID-19 Vaccination and HBsAg Loss in Chronic Hepatitis B Infection: An Interrupted Time Series AnalysisJonggi Choi, Allison Carroll, Vy H Nguyen, et al.
International Urogynecology Journal|June 6, 2022
Mesh complications after total vs supracervical laparoscopic hysterectomy at time of minimally invasive sacrocolpopexyDeepanjana Das, Allison Carroll, Margaret Mueller, et al.
Hepatology (Baltimore, Md.)|May 22, 2021
TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard-of-Care TherapyGabriel M Knight, Jeffrey Clark, Justin R Boike, et al.
The American Journal of Gastroenterology|December 16, 2025
Association of SGLT2 Inhibitors with Reduced Hepatocellular Carcinoma Risk in Patients with Type 2 DiabetesJonggi Choi, Vy H Nguyen, Eric Przybyszewski, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 30, 2018
Predictors of Varenicline Adherence Among Cancer Patients Treated for Tobacco Dependence and its Association With Smoking CessationGrace Crawford, Jessica Weisbrot, Joseph Bastian, et al.
JAMA Internal Medicine|March 17, 2025
Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver DiseaseJonggi Choi, Vy H Nguyen, Eric Przybyszewski, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|November 15, 2023
Organ Donation in Canadian PICUs: A Cross-Sectional Survey, 2021-2022Laurie A Lee, Dori-Ann Martin, Meagan Mahoney, et al.
Hepatology Communications|April 13, 2026
GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetesJonggi Choi, Gabby Mitchell, Vy H Nguyen, et al.
Clinical and Molecular Hepatology|November 11, 2025
Comparative Risk of Fibrosis Progression with SGLT2 vs. DPP-4 Inhibitors in MASLD and T2DM with Low-to-Intermediate FibrosisJonggi Choi, Daniel Fulop, Vy H Nguyen, et al.
Pageof 4